13F

Stock

Prelude Therapeutics Inc

PRLD · held by 1 managers

Reported value

$41.1K

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$8.53K

Price effect on 1 books still in the name

Largest holder

$41.1K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC13.3K$41.1K−$8.53KAdded$13.9K

Positions as of Q3 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.